ArticleHealth science reports2019
Bortezomib retreatment for relapsed and refractory multiple myeloma in real-world clinical practice.
Cyrille Hulin et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
15 papers cite it
this papercites it